Somatics became aware of this event on the maude website in early april.The patient submitted medwatch report provided by fda was received on april 20, 2020.It referenced the event date of (b)(6) 2010.It does not provide any contact information for the treating physician or facility, nor any additional information about the circumstances surrounding the reported event.The report also does not provide any laboratory results or other objective information to corroborate the complainant's description of the adverse effects suffered in relation to electroconvulsive therapy.Somatics sent a return receipt letter requesting documentation of the missing information above.When received back, somatics will update this report if it is deemed warranted.Because of the lack of identifying information and specifics in the report, somatics is unable to determine if the complainant was even treated with its thymatron device.Moreover, the medical literature provides no evidence of the connection drawn by the complainant between ect treatment and the symptoms reported.Although the company has determined that the subject event in this mdr is likely not reportable, because somatics is unable to determine whether the ect device in question was even the one manufactured by somatics, the company is submitting this report to fda in an abundance of caution and to ensure full compliance with 21 cfr part 803.
|